Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease

Parkinson’s disease (PD) is a common neurodegenerative disease, and the mechanism underlying PD pathogenesis is not completely understood. Increasing evidence indicates that microRNAs (miRNAs) play a critical regulatory role in the pathogenesis of PD. This study aimed to explore the miRNA-mRNA regul...

Full description

Saved in:
Bibliographic Details
Main Authors: Xi Yin, Miao Wang, Wei Wang, Tong Chen, Ge Song, Yixuan Niu, Ziying Jiang, Zhongbao Gao, Zhenfu Wang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2022/2877728
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562363794980864
author Xi Yin
Miao Wang
Wei Wang
Tong Chen
Ge Song
Yixuan Niu
Ziying Jiang
Zhongbao Gao
Zhenfu Wang
author_facet Xi Yin
Miao Wang
Wei Wang
Tong Chen
Ge Song
Yixuan Niu
Ziying Jiang
Zhongbao Gao
Zhenfu Wang
author_sort Xi Yin
collection DOAJ
description Parkinson’s disease (PD) is a common neurodegenerative disease, and the mechanism underlying PD pathogenesis is not completely understood. Increasing evidence indicates that microRNAs (miRNAs) play a critical regulatory role in the pathogenesis of PD. This study aimed to explore the miRNA-mRNA regulatory network for PD. The differentially expressed miRNAs (DEmis) and genes (DEGs) between PD patients and healthy donors were screened from the miRNA dataset GSE16658 and mRNA dataset GSE100054 downloaded from the Gene Expression Omnibus (GEO) database. Target genes of the DEmis were selected when they were predicted by three or four online databases and overlapped with DEGs from GSE100054. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then conducted by Database for Annotation, Visualization and Integrated Discovery (DAVID) and Metascape analytic tools. The correlation between the screened genes and PD was evaluated with the online tool Comparative Toxicogenomics Database (CTD), and protein-protein interaction (PPI) networks were built by the STRING platform. We further investigated the expression of genes in the miRNA-mRNA regulatory network in blood samples collected from PD patients and healthy donors via qRT-PCR. We identified 1505 upregulated and 1302 downregulated DEGs, and 77 upregulated and 112 downregulated DEmis were preliminarily screened from the GEO database. Further functional enrichment analysis identified 10 PD-related hub genes, including RAC1, IRS2, LEPR, PPARGC1A, CAMKK2, RAB10, RAB13, RAB27B, RAB11A, and JAK2, which were mainly involved in Rab protein signaling transduction, AMPK signaling pathway, and signaling by Leptin. A miRNA-mRNA regulatory network was then constructed with 10 hub genes, and their interacting miRNAs overlapped with DEmis, including miR-30e-5p, miR-142-3p, miR-101-3p, miR-32-3p, miR-508-5p, miR-642a-5p, miR-19a-3p, and miR-21-5p. Analysis of clinical samples verified significant upregulation of LEPR and downregulation of miR-101-3p and miR-30e-5p in PD patients as compared with healthy donors. Thus, the miRNA-mRNA regulatory network was initially constructed and has the potential to provide novel insights into the pathogenesis and treatment of PD.
format Article
id doaj-art-bf8c725eda184e8ba6fa669da5709703
institution Kabale University
issn 2042-0080
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-bf8c725eda184e8ba6fa669da57097032025-02-03T01:22:49ZengWileyParkinson's Disease2042-00802022-01-01202210.1155/2022/2877728Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s DiseaseXi Yin0Miao Wang1Wei Wang2Tong Chen3Ge Song4Yixuan Niu5Ziying Jiang6Zhongbao Gao7Zhenfu Wang8Department of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of GeriatricsDepartment of GeriatricsDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyParkinson’s disease (PD) is a common neurodegenerative disease, and the mechanism underlying PD pathogenesis is not completely understood. Increasing evidence indicates that microRNAs (miRNAs) play a critical regulatory role in the pathogenesis of PD. This study aimed to explore the miRNA-mRNA regulatory network for PD. The differentially expressed miRNAs (DEmis) and genes (DEGs) between PD patients and healthy donors were screened from the miRNA dataset GSE16658 and mRNA dataset GSE100054 downloaded from the Gene Expression Omnibus (GEO) database. Target genes of the DEmis were selected when they were predicted by three or four online databases and overlapped with DEGs from GSE100054. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then conducted by Database for Annotation, Visualization and Integrated Discovery (DAVID) and Metascape analytic tools. The correlation between the screened genes and PD was evaluated with the online tool Comparative Toxicogenomics Database (CTD), and protein-protein interaction (PPI) networks were built by the STRING platform. We further investigated the expression of genes in the miRNA-mRNA regulatory network in blood samples collected from PD patients and healthy donors via qRT-PCR. We identified 1505 upregulated and 1302 downregulated DEGs, and 77 upregulated and 112 downregulated DEmis were preliminarily screened from the GEO database. Further functional enrichment analysis identified 10 PD-related hub genes, including RAC1, IRS2, LEPR, PPARGC1A, CAMKK2, RAB10, RAB13, RAB27B, RAB11A, and JAK2, which were mainly involved in Rab protein signaling transduction, AMPK signaling pathway, and signaling by Leptin. A miRNA-mRNA regulatory network was then constructed with 10 hub genes, and their interacting miRNAs overlapped with DEmis, including miR-30e-5p, miR-142-3p, miR-101-3p, miR-32-3p, miR-508-5p, miR-642a-5p, miR-19a-3p, and miR-21-5p. Analysis of clinical samples verified significant upregulation of LEPR and downregulation of miR-101-3p and miR-30e-5p in PD patients as compared with healthy donors. Thus, the miRNA-mRNA regulatory network was initially constructed and has the potential to provide novel insights into the pathogenesis and treatment of PD.http://dx.doi.org/10.1155/2022/2877728
spellingShingle Xi Yin
Miao Wang
Wei Wang
Tong Chen
Ge Song
Yixuan Niu
Ziying Jiang
Zhongbao Gao
Zhenfu Wang
Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
Parkinson's Disease
title Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
title_full Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
title_fullStr Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
title_full_unstemmed Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
title_short Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
title_sort identification of potential mirna mrna regulatory network contributing to parkinson s disease
url http://dx.doi.org/10.1155/2022/2877728
work_keys_str_mv AT xiyin identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT miaowang identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT weiwang identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT tongchen identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT gesong identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT yixuanniu identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT ziyingjiang identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT zhongbaogao identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease
AT zhenfuwang identificationofpotentialmirnamrnaregulatorynetworkcontributingtoparkinsonsdisease